| Phase I study of the indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (atezolizumab) in advanced solid tumors KH Jung, P LoRusso, H Burris, M Gordon, YJ Bang, MD Hellmann, ... Clinical Cancer Research 25 (11), 3220-3228, 2019 | 198 | 2019 |
| Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture Y Guo, T Saunders, H Su, H Kim, D Akkoc, DA Saloner, SW Hetts, C Hess, ... Stroke 43 (5), 1240-1246, 2012 | 93 | 2012 |
| Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: quantitative assessment A Bharatha, ME Faughnan, H Kim, T Pourmohamad, T Krings, ... Stroke 43 (1), 72-78, 2012 | 93 | 2012 |
| Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene–phenotype correlations T Nishida, ME Faughnan, T Krings, M Chakinala, JR Gossage, WL Young, ... American Journal of Medical Genetics Part A 158 (11), 2829-2834, 2012 | 89 | 2012 |
| Cerebellar arteriovenous malformations: anatomic subtypes, surgical results, and increased predictive accuracy of the supplementary grading system A Rodríguez-Hernández, H Kim, T Pourmohamad, WL Young, MT Lawton Neurosurgery 71 (6), 1111-1124, 2012 | 80 | 2012 |
| An admission bioclinical score to predict 1-year outcomes in patients undergoing aneurysm coiling V Degos, CC Apfel, P Sanchez, C Colonne, I Renuit, F Clarençon, ... Stroke 43 (5), 1253-1259, 2012 | 33 | 2012 |
| Evaluating performance of the Spetzler-Martin supplemented model in selecting patients with brain arteriovenous malformation for surgery H Kim, T Pourmohamad, EM Westbroek, CE McCulloch, MT Lawton, ... Stroke 43 (9), 2497-2499, 2012 | 29 | 2012 |
| Investigating the value of urine volume, creatinine, and cystatin C for urinary biomarkers normalization for drug development studies AO Adedeji, T Pourmohamad, Y Chen, J Burkey, CJ Betts, SJ Bickerton, ... International journal of toxicology 38 (1), 12-22, 2019 | 27 | 2019 |
| First-In-Human phase I study of the OX40 agonist MOXR0916 in patients with advanced solid tumors TW Kim, HA Burris III, MJ de Miguel Luken, MJ Pishvaian, YJ Bang, ... Clinical Cancer Research 28 (16), 3452-3463, 2022 | 24 | 2022 |
| Multivariate stochastic process models for correlated responses of mixed type T Pourmohamad, HKH Lee | 24 | 2016 |
| University of California, San Francisco Arteriovenous Malformation Study Project. Cerebellar arteriovenous malformations: anatomic subtypes, surgical results, and increased … A Rodríguez-Hernández, H Kim, T Pourmohamad, WL Young, MT Lawton Neurosurgery 71 (6), 1111-1124, 2012 | 23 | 2012 |
| The statistical filter approach to constrained optimization T Pourmohamad, HKH Lee Technometrics 62 (3), 303-312, 2020 | 19 | 2020 |
| Bayesian optimization via barrier functions T Pourmohamad, HKH Lee Journal of Computational and Graphical Statistics 31 (1), 74-83, 2022 | 17 | 2022 |
| Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors CD Weekes, LS Rosen, A Capasso, KM Wong, W Ye, M Anderson, ... Cancer Chemotherapy and Pharmacology 82, 339-351, 2018 | 15 | 2018 |
| Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissue MP Kahle, B Lee, T Pourmohamad, A Cunningham, H Su, H Kim, Y Chen, ... Neuroreport 23 (10), 627-630, 2012 | 15 | 2012 |
| University of California, San Francisco Brain Arteriovenous Malformation (UCSF bAVM) Study Project. Silent intralesional microhemorrhage as a risk factor for brain … Y Guo, T Saunders, H Su, H Kim, D Akkoc, DA Saloner, SW Hetts, C Hess, ... Stroke 43, 1240-1246, 2012 | 14 | 2012 |
| Bayesian optimization with application to computer experiments T Pourmohamad, HKH Lee Springer, 2021 | 12 | 2021 |
| University of California SFAMSP. Cerebellar arteriovenous malformations: anatomic subtypes, surgical results, and increased predictive accuracy of the supplementary grading system A Rodriguez-Hernandez, H Kim, T Pourmohamad, WL Young, MT Lawton Neurosurgery 71 (6), 1111-24, 2012 | 10 | 2012 |
| Bimodal expression of potential drug target CLL‐1 (CLEC12A) on CD34+ blasts of AML patients LL Ngai, CY Ma, O Maguire, AD Do, A Robert, AC Logan, EA Griffiths, ... European journal of haematology 107 (3), 343-353, 2021 | 7 | 2021 |
| A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia N Daver, A Salhotra, JM Brandwein, NA Podoltsev, DA Pollyea, JG Jurcic, ... American journal of hematology 96 (5), E175-E179, 2021 | 7 | 2021 |
